Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats

Critical Care

Volumn 12, Issue 2, 2008, Pages

  Hagiwara, Satoshi ^a   Iwasaka, Hideo ^a   Hidaka, Seigo ^a   Hishiyama, Sohei ^a   Noguchi, Takayuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DANAPAROID; ENDOTOXIN; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; CHONDROITIN SULFATE; DERMATAN SULFATE; HEPARAN SULFATE; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HISTOPATHOLOGY; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MALE; MEDIATOR; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SUPERNATANT; SURVIVAL RATE; TISSUE LEVEL; WISTAR RAT; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; BLOOD; METABOLISM; PATHOLOGY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; CHONDROITIN SULFATES; DERMATAN SULFATE; ENDOTOXINS; HEPARITIN SULFATE; HMGB1 PROTEIN; I-KAPPA B PROTEINS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MICE; NF-KAPPA B; RATS; RATS, WISTAR; RESPIRATORY DISTRESS SYNDROME, ADULT; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42949148210     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6851     Document Type: Article

References (34)

1. Ware LB Matthay MA The acute respiratory distress syndrome N Engl J Med 2000, 342:1334-1349. 10.1056/NEJM200005043421806 10793167
2. Bhatia M Moochhala S Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome J Pathol 2004, 202:145-156. 10.1002/path.1491 14743496
3. Ghosh S Latimer RD Gray BM Harwood RJ Oduro A Endotoxin-induced organ injury Crit Care Med 1993, 21:S19-24. 10.1097/00003246-199302001-00005 8428492
4. Bustin M Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins Mol Cell Biol 1999, 19:5237-5246. 84367 10409715
5. Wang H Bloom O Zhang M Vishnubhakat JM Ombrellino M Che J Frazier A Yang H Ivanova S Borovikova L Manogue KR Faist E Abraham E Andersson J Andersson U Molina PE Abumrad NN Sama A Tracey KJ HMG-1 as a late mediator of endotoxin lethality in mice Science 1999, 285:248-251. 10.1126/science.285.5425.248 10398600
6. Fiuza C Bustin M Talwar S Tropea M Gerstenberger E Shelhamer JH Suffredini AF Inflammation-promoting activity of HMGB1 on human micro vascular endothelial cells Blood 2003, 101:2652-2660. 10.1182/ blood-2002-05-1300 12456506
7. Park JS Gamboni-Robertson F He Q Svetkauskaite D Kim JY Strassheim D Sohn JW Yamada S Maruyama I Banerjee A Ishizaka A Abraham E High Mobility Group Box 1 protein (HMGB1) interacts with multiple Toll like receptors Am J Physiol Cell Physiol 2006, 290:917-924. 10.1152/ ajpcell.00401.2005
8. Kokkola R Andersson A Mullins G Ostberg T Treutiger CJ Arnold B Nawroth P Andersson U Harris RA Harris HE RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages Scand J Immunol 2005, 61:1-9. 10.1111/j.0300-9475.2005.01534.x 15644117
9. Iba T Kidokoro A Yagi Y The role of the endothelium in changes in procoagulant activity J Am Coll Surg 1998, 87:321-329. 10.1016/ S1072-7515(98)00177-X
10. Macfarlane SR Seatter MJ Kanke T Hunter GD Plevin R Proteinase-activated receptors Pharmacol Rev 2001, 53:245-282. 11356985
11. Meuleman DG Orgaran (Org10172): Its pharmacological profile in experimental models Haemostasis 1992, 22:58-65. 1379965
12. Iba T Kidokoro A Fukunaga M Fuse S Suda M Kunitada S Hara T Factor Xa-inhibitor (DX-9065a) modulates the leukocyte-endothelial cell interaction in endotoxemic rat Shock 2002, 17:159-162. 10.1097/ 00024382-200202000-00013 11837793
13. Iba T Kidokoro A Fukunaga M Nagakari K Suda M Yoshikawa S Ida Y Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin Intensive Care Med 2005, 31:1101-1108. 10.1007/ s00134-005-2707-0 15995859
14. Freeman BD Zehnbauer BA Buchman TG A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis Shock 2003, 20:5-9. 10.1097/01.shk.0000068327.26733.10 12813361
15. Matthay MA Severe sepsis: A new treatment with both anticoagulant and anti-inflammatory properties N Engl J Med 2001, 344:759-762. 10.1056/ NEJM200103083441009 11236781
16. Murakami K McGuire R Cox RA Jodoin JM Bjertnaes LJ Katahira J Traber LD Schmalstieg FC Hawkins HK Herndon DN Traber DL Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep Shock 2002, 18:236-241. 10.1097/00024382-200209000-00006 12353924
17. Schultz MJ Haitsma JJ Zhang H Slutsky AS Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia - a review Crit Care Med 2006, 34:871-877. 16521285
18. Feistritzer C Wiedermann CJ Effects of anticoagulant strategies on activation of inflammation and coagulation Expert Opin Biol Ther 2007, 7:855-870. 10.1517/14712598.7.6.855 17555371
19. Ward PA Role of complement, chemokines, and regulatory cytokines in acute lung injury Ann NY Acad Sci 1996, 796:104-112. 10.1111/ j.1749-6632.1996.tb32572.x 8906217
20. Yang H Wang H Tracey KJ HMG-1 rediscovered as a cytokine Shock 2001, 15:247-253. 11303722
21. Ueno H Matsuda T Hashimoto S Amaya F Kitamura Y Tanaka M Kobayashi A Maruyama I Yamada S Hasegawa N Soejima J Koh H Ishizaka A Contributions of high mobility group box protein in experimental and clinical acute lung injury Am J Respir Crit Care Med 2004, 170:1310-1316. 10.1164/ rccm.200402-188OC 15374839
22. Angus DC Yang L Kong L Kellum JA Delude RL Tracey KJ Weissfeld L GenIMS Investigators Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis Crit Care Med 2007, 35:1061-1067. 10.1097/ 01.CCM.0000259534.68873.2A 17334246
23. Fiorentino DF Zlotnik A Mosmann TR Howard M O'Garra A IL-10 inhibits cytokine production by activated macrophages J Immunol 1991, 147:3815-3822. 1940369
24. O'Farrell AM Liu Y Moore KW Mui AL IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and -independent pathways EMBO J 1998, 17:1006-1018. 1170450 9463379 10.1093/emboj/17.4.1006
25. Bogdan C Vodovotz Y Nathan C Macrophage deactivation by interleukin-10 J Exp Med 1991, 174:1549-1555. 2119047 1744584 10.1084/jem.174.6.1549
26. Donnelly SC Strieter RM Reid PT Kunkel SL Burdick MD Armstrong I Mackenzie A Haslett C The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome Ann Intern Med 1996, 125:191-196. 8686976
27. Sheehan M Wong H Hake PW Malhotra V O'Connor M Zingarelli B Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents Mol Pharmacol 2002, 61:953-963. 10.1124/mol.61.5.953 11961112
28. Kang YJ Seo SJ Yun-Choi HS Lee DH Kim YM Chang KC A synthetic isoquinoline alkaloid, 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (YS 51), reduces inducible nitric oxide synthase expression and improves survival in a rodent model of endotoxic shock J Pharmacol Exp Ther 2002, 301:561-567. 10.1124/jpet.301.2.561 11961057
29. Adcock IM Transcription factors as activators of gene transcription: AP-1 and NF-kappa B Monaldi Arch Chest Dis 1997, 52:178-186. 9203818
30. Esmon CT Role of coagulation inhibitors in inflammation Thromb Haemost 2001, 86:51-56. 11487041
31. Riewald M Kravchenko VV Petrovan RJ O'Brien PJ Brass LF Ulevitch RJ Ruf W Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1 Blood 2001, 97:3109-3116. 10.1182/ blood.V97.10.3109 11342437
32. Skoutakis VA Danaparoid in the prevention of thromboembolic complications Ann Pharmacother 1997, 31:876-887. 9220051
33. Kwak HJ Song JS Heo JY Yang SD Nam JY Cheon HG Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation J Pharmacol Exp Ther 2005, 315:1188-1195. 10.1124/jpet.105.092056 16126838
34. Schottelius AJ Mayo MW Sartor RB Baldwin AS Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding J Biol Chem 1999, 274:31868-31874. 10.1074/jbc.274.45.31868 10542212